Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress COHN Q1 2026 Earnings Positive EPS Despite Sparse Data Stock Edges Lower MXC Q3 2025 Earnings Positive EPS of 022 Amid Quiet Quarter PBHC Q4 2025 Earnings Negative EPS of 111 Amidst a Challenging Quarter COYA Q1 2026 Earnings NarrowerThanExpected Loss Despite No Recognized Revenue APD Q1 2026 Earnings EPS Beats Estimates but Stock Slips